Share Price and Basic Stock Data
Last Updated: December 5, 2025, 4:52 am
| PEG Ratio | -3.17 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ambica Agarbathies Aroma & Industries Ltd operates in the personal care sector, focusing on the production of incense sticks and related products. The company’s stock price stood at ₹25.3, with a market capitalization of ₹43.3 Cr. Over the past quarters, Ambica has experienced fluctuating sales figures. In Jun 2022, reported sales were ₹20.93 Cr, which increased to ₹35.16 Cr by Mar 2023. However, sales declined to ₹21.25 Cr in Jun 2023 before recovering to ₹24.31 Cr in Sep 2023. The total sales for the trailing twelve months (TTM) reached ₹131 Cr. This indicates a capacity for growth despite the volatility. The operating profit margin (OPM) varied significantly, peaking at 15.30% in Jun 2024, reflecting operational efficiency. The company’s historical annual sales reached a high of ₹168 Cr in Mar 2020, but have since seen a downward trend, with a recorded ₹98 Cr for Mar 2024. The revenue trajectory indicates potential for recovery, dependent on market conditions and operational adjustments.
Profitability and Efficiency Metrics
Ambica’s profitability metrics reveal a mixed performance. The company’s net profit for the most recent quarter (Jun 2025) was ₹1.14 Cr, showing improvement from a net profit of ₹0.22 Cr in Mar 2024. However, the company has also recorded losses in various quarters, including a net loss of ₹1.62 Cr in Jun 2023. The price-to-earnings (P/E) ratio is notably high at 85.0, indicating that investors are paying a premium for earnings, possibly due to growth expectations or market positioning. The return on equity (ROE) stood at 0.45%, while return on capital employed (ROCE) was recorded at 7.49%. These figures suggest that while the company is generating some returns, they are below typical sector benchmarks, which often hover around 10% for similar companies. The operating profit margin (OPM) averaged 10.25%, reflecting challenges in cost management despite some operational efficiencies.
Balance Sheet Strength and Financial Ratios
The balance sheet of Ambica Agarbathies reveals a significant reliance on borrowings, which stood at ₹84 Cr against reserves of ₹95 Cr. The total liabilities were reported at ₹224 Cr, highlighting a leveraged position that may pose risks in times of financial stress. The current ratio is a solid 2.69, indicating good short-term liquidity, while the quick ratio of 2.52 further supports this assessment. However, the interest coverage ratio (ICR) is at 1.43, suggesting that the company only marginally covers its interest obligations, which could be a concern if profitability does not stabilize. The debt-to-equity ratio was recorded at 0.68, which is within acceptable limits but still indicates a moderate level of financial risk. The book value per share stood at ₹63.62, presenting a substantial cushion against market fluctuations. Overall, while the balance sheet shows some strengths, the reliance on debt and moderate profitability metrics warrant caution.
Shareholding Pattern and Investor Confidence
Ambica’s shareholding structure reflects a significant public stake of 56.58%, with promoters holding 43.41%. This distribution indicates a stable ownership structure, although the slight decline in promoter holding from 48.35% in Dec 2022 to the current level may raise concerns about insider confidence. Foreign institutional investors (FIIs) have maintained a consistent 0.00% stake, which could suggest a lack of interest or confidence from institutional investors in the company’s growth prospects. The total number of shareholders decreased from 9,256 in Dec 2022 to 8,669 as of Sep 2025, indicating potential investor fatigue or a shift in sentiment. Despite this, the public’s substantial holding may provide a buffer against volatility. The shareholding dynamics could influence investor confidence moving forward, especially if the company can demonstrate sustained profitability and operational improvements.
Outlook, Risks, and Final Insight
The outlook for Ambica Agarbathies hinges on its ability to enhance profitability and manage its financial leverage effectively. While the company has reported improvements in some profitability metrics, the high P/E ratio and fluctuating net profits indicate investor caution. Key risks include reliance on debt, as evidenced by its significant borrowings compared to reserves, and the potential for operational inefficiencies that could hinder growth. Additionally, the decline in promoter shareholding raises questions about insider confidence, which could further impact market sentiment. Conversely, strengths such as a robust public shareholding structure and improving sales trends could provide a foundation for recovery. If Ambica can stabilize its earnings and manage costs effectively, it may position itself for a more favorable market perception in the personal care sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ambica Agarbathies Aroma & Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,050 Cr. | 278 | 334/190 | 72.7 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 43.7 Cr. | 25.4 | 37.0/23.3 | 85.7 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 124 Cr. | 129 | 129/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 589 Cr. | 388 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 10,776 Cr. | 293 | 433/268 | 29.4 | 55.8 | 1.19 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 71,572.86 Cr | 1,921.01 | 57.70 | 112.70 | 0.75% | 29.21% | 23.91% | 4.94 |
All Competitor Stocks of Ambica Agarbathies Aroma & Industries Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.93 | 29.20 | 31.95 | 35.16 | 21.25 | 24.31 | 28.93 | 23.35 | 23.01 | 33.51 | 36.05 | 31.05 | 30.14 |
| Expenses | 20.75 | 28.31 | 28.87 | 31.93 | 20.23 | 23.87 | 27.20 | 22.75 | 19.49 | 30.42 | 33.70 | 29.78 | 27.05 |
| Operating Profit | 0.18 | 0.89 | 3.08 | 3.23 | 1.02 | 0.44 | 1.73 | 0.60 | 3.52 | 3.09 | 2.35 | 1.27 | 3.09 |
| OPM % | 0.86% | 3.05% | 9.64% | 9.19% | 4.80% | 1.81% | 5.98% | 2.57% | 15.30% | 9.22% | 6.52% | 4.09% | 10.25% |
| Other Income | 0.00 | 2.76 | 0.72 | 1.88 | 0.01 | 0.49 | 0.03 | 4.82 | 1.05 | 1.42 | 1.51 | 1.33 | 1.74 |
| Interest | 1.83 | 1.74 | 1.76 | 2.51 | 2.06 | 2.09 | 2.07 | 3.49 | 2.65 | 2.84 | 2.93 | 2.44 | 2.72 |
| Depreciation | 0.82 | 0.82 | 0.82 | -0.60 | 0.46 | 0.46 | 0.46 | 0.31 | 0.42 | 0.42 | 0.42 | 0.73 | 0.59 |
| Profit before tax | -2.47 | 1.09 | 1.22 | 3.20 | -1.49 | -1.62 | -0.77 | 1.62 | 1.50 | 1.25 | 0.51 | -0.57 | 1.52 |
| Tax % | -18.22% | 0.00% | -36.89% | 44.69% | 8.72% | -8.02% | 0.00% | 86.42% | 25.33% | 25.60% | 25.49% | 240.35% | 25.00% |
| Net Profit | -2.02 | 1.10 | 1.67 | 1.78 | -1.62 | -1.49 | -0.77 | 0.22 | 1.12 | 0.93 | 0.38 | -1.94 | 1.14 |
| EPS in Rs | -1.18 | 0.64 | 0.97 | 1.04 | -0.94 | -0.87 | -0.45 | 0.13 | 0.65 | 0.54 | 0.22 | -1.13 | 0.66 |
Last Updated: August 19, 2025, 11:55 pm
Below is a detailed analysis of the quarterly data for Ambica Agarbathies Aroma & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 30.14 Cr.. The value appears to be declining and may need further review. It has decreased from 31.05 Cr. (Mar 2025) to 30.14 Cr., marking a decrease of 0.91 Cr..
- For Expenses, as of Jun 2025, the value is 27.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 29.78 Cr. (Mar 2025) to 27.05 Cr., marking a decrease of 2.73 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.09 Cr.. The value appears strong and on an upward trend. It has increased from 1.27 Cr. (Mar 2025) to 3.09 Cr., marking an increase of 1.82 Cr..
- For OPM %, as of Jun 2025, the value is 10.25%. The value appears strong and on an upward trend. It has increased from 4.09% (Mar 2025) to 10.25%, marking an increase of 6.16%.
- For Other Income, as of Jun 2025, the value is 1.74 Cr.. The value appears strong and on an upward trend. It has increased from 1.33 Cr. (Mar 2025) to 1.74 Cr., marking an increase of 0.41 Cr..
- For Interest, as of Jun 2025, the value is 2.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.44 Cr. (Mar 2025) to 2.72 Cr., marking an increase of 0.28 Cr..
- For Depreciation, as of Jun 2025, the value is 0.59 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.73 Cr. (Mar 2025) to 0.59 Cr., marking a decrease of 0.14 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.52 Cr.. The value appears strong and on an upward trend. It has increased from -0.57 Cr. (Mar 2025) to 1.52 Cr., marking an increase of 2.09 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 240.35% (Mar 2025) to 25.00%, marking a decrease of 215.35%.
- For Net Profit, as of Jun 2025, the value is 1.14 Cr.. The value appears strong and on an upward trend. It has increased from -1.94 Cr. (Mar 2025) to 1.14 Cr., marking an increase of 3.08 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.66. The value appears strong and on an upward trend. It has increased from -1.13 (Mar 2025) to 0.66, marking an increase of 1.79.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94 | 98 | 104 | 119 | 125 | 138 | 168 | 143 | 116 | 117 | 98 | 124 | 131 |
| Expenses | 80 | 83 | 91 | 107 | 131 | 126 | 153 | 138 | 102 | 109 | 93 | 113 | 121 |
| Operating Profit | 14 | 14 | 13 | 12 | -5 | 12 | 14 | 6 | 14 | 8 | 5 | 10 | 10 |
| OPM % | 15% | 15% | 12% | 10% | -4% | 9% | 8% | 4% | 12% | 7% | 5% | 8% | 8% |
| Other Income | 1 | 1 | 1 | 2 | 2 | 3 | 0 | 4 | 1 | 5 | 5 | 5 | 6 |
| Interest | 10 | 9 | 9 | 9 | 9 | 8 | 8 | 7 | 12 | 9 | 11 | 11 | 11 |
| Depreciation | 4 | 4 | 3 | 3 | 5 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Profit before tax | 1 | 2 | 2 | 2 | -17 | 4 | 4 | -0 | 1 | 3 | -2 | 3 | 3 |
| Tax % | 20% | 26% | 33% | 32% | 3% | -188% | -17% | -648% | -300% | 17% | 62% | 81% | |
| Net Profit | 1 | 1 | 1 | 2 | -18 | 10 | 4 | 3 | 2 | 3 | -4 | 0 | 1 |
| EPS in Rs | 0.62 | 0.84 | 0.79 | 0.90 | -10.37 | 5.97 | 2.48 | 1.60 | 1.40 | 1.47 | -2.13 | 0.29 | 0.29 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -1000.00% | 155.56% | -60.00% | -25.00% | -33.33% | 50.00% | -233.33% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -1100.00% | 1155.56% | -215.56% | 35.00% | -8.33% | 83.33% | -283.33% | 333.33% |
Ambica Agarbathies Aroma & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -6% |
| 3 Years: | 2% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -21% |
| 3 Years: | -15% |
| TTM: | 155% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | % |
| 3 Years: | -7% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 0% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:21 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 17 | 19 | 19 | 20 | 68 | 76 | 80 | 83 | 85 | 88 | 84 | 92 | 95 |
| Borrowings | 64 | 58 | 58 | 58 | 77 | 67 | 66 | 69 | 64 | 63 | 67 | 82 | 84 |
| Other Liabilities | 23 | 16 | 17 | 19 | 40 | 34 | 41 | 42 | 53 | 36 | 43 | 32 | 29 |
| Total Liabilities | 121 | 110 | 111 | 114 | 202 | 194 | 204 | 212 | 219 | 204 | 211 | 224 | 224 |
| Fixed Assets | 42 | 39 | 38 | 45 | 132 | 129 | 126 | 125 | 122 | 122 | 120 | 130 | 129 |
| CWIP | 12 | 14 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| Investments | 0 | 0 | 0 | 5 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 10 | 11 |
| Other Assets | 67 | 56 | 63 | 64 | 64 | 59 | 71 | 80 | 90 | 74 | 79 | 84 | 84 |
| Total Assets | 121 | 110 | 111 | 114 | 202 | 194 | 204 | 212 | 219 | 204 | 211 | 224 | 224 |
Below is a detailed analysis of the balance sheet data for Ambica Agarbathies Aroma & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
- For Reserves, as of Sep 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2025) to 95.00 Cr., marking an increase of 3.00 Cr..
- For Borrowings, as of Sep 2025, the value is 84.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 82.00 Cr. (Mar 2025) to 84.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 29.00 Cr.. The value appears to be improving (decreasing). It has decreased from 32.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 224.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 224.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 129.00 Cr.. The value appears to be declining and may need further review. It has decreased from 130.00 Cr. (Mar 2025) to 129.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 84.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 84.00 Cr..
- For Total Assets, as of Sep 2025, the value is 224.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 224.00 Cr..
Notably, the Reserves (95.00 Cr.) exceed the Borrowings (84.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -50.00 | -44.00 | -45.00 | -46.00 | -82.00 | -55.00 | -52.00 | -63.00 | -50.00 | -55.00 | -62.00 | -72.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28 | 32 | 26 | 26 | 36 | 38 | 46 | 21 | 91 | 60 | 35 | 42 |
| Inventory Days | 89 | 129 | 157 | 104 | 7 | 12 | 38 | 42 | 57 | 10 | 30 | 22 |
| Days Payable | 26 | 17 | 25 | 41 | 13 | 12 | 25 | 42 | 108 | 17 | 71 | 15 |
| Cash Conversion Cycle | 91 | 144 | 158 | 89 | 30 | 37 | 59 | 21 | 40 | 53 | -6 | 49 |
| Working Capital Days | 69 | 20 | -19 | -66 | 49 | 68 | 72 | 95 | 111 | 162 | 197 | 144 |
| ROCE % | 11% | 12% | 12% | 11% | -7% | 7% | 7% | 4% | 7% | 7% | 5% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.66 | -2.13 | 1.47 | 1.40 | 1.59 |
| Diluted EPS (Rs.) | 4.66 | -2.13 | 1.47 | 1.40 | 1.59 |
| Cash EPS (Rs.) | 1.45 | -1.15 | 2.54 | 3.30 | 3.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 63.62 | 58.96 | 61.09 | 59.63 | 58.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 63.62 | 58.96 | 61.09 | 59.63 | 58.24 |
| Revenue From Operations / Share (Rs.) | 71.96 | 56.96 | 68.25 | 67.72 | 83.48 |
| PBDIT / Share (Rs.) | 9.05 | 5.75 | 7.82 | 8.95 | 5.87 |
| PBIT / Share (Rs.) | 7.89 | 4.77 | 6.75 | 7.05 | 4.04 |
| PBT / Share (Rs.) | 1.57 | -1.31 | 1.78 | 0.34 | -0.29 |
| Net Profit / Share (Rs.) | 0.28 | -2.13 | 1.47 | 1.40 | 1.59 |
| PBDIT Margin (%) | 12.58 | 10.10 | 11.45 | 13.21 | 7.03 |
| PBIT Margin (%) | 10.96 | 8.37 | 9.88 | 10.41 | 4.83 |
| PBT Margin (%) | 2.17 | -2.30 | 2.60 | 0.51 | -0.34 |
| Net Profit Margin (%) | 0.39 | -3.74 | 2.15 | 2.06 | 1.90 |
| Return on Networth / Equity (%) | 0.44 | -3.61 | 2.40 | 2.34 | 2.73 |
| Return on Capital Employeed (%) | 6.99 | 4.29 | 6.14 | 6.55 | 3.62 |
| Return On Assets (%) | 0.21 | -1.73 | 1.24 | 1.09 | 1.29 |
| Long Term Debt / Equity (X) | 0.54 | 0.66 | 0.59 | 0.60 | 0.69 |
| Total Debt / Equity (X) | 0.68 | 0.66 | 0.59 | 0.62 | 0.69 |
| Asset Turnover Ratio (%) | 0.56 | 0.47 | 0.55 | 0.54 | 0.68 |
| Current Ratio (X) | 2.69 | 3.66 | 4.51 | 2.08 | 2.96 |
| Quick Ratio (X) | 2.52 | 3.39 | 4.34 | 1.70 | 2.29 |
| Inventory Turnover Ratio (X) | 4.76 | 4.36 | 4.33 | 0.75 | 0.83 |
| Interest Coverage Ratio (X) | 1.43 | 0.94 | 1.57 | 1.34 | 1.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.04 | 0.64 | 1.30 | 1.21 | 1.37 |
| Enterprise Value (Cr.) | 120.12 | 111.28 | 96.69 | 107.30 | 73.46 |
| EV / Net Operating Revenue (X) | 0.97 | 1.14 | 0.82 | 0.92 | 0.51 |
| EV / EBITDA (X) | 7.72 | 11.26 | 7.20 | 6.98 | 7.28 |
| MarketCap / Net Operating Revenue (X) | 0.37 | 0.46 | 0.29 | 0.38 | 0.04 |
| Price / BV (X) | 0.42 | 0.44 | 0.33 | 0.44 | 0.06 |
| Price / Net Operating Revenue (X) | 0.37 | 0.46 | 0.29 | 0.38 | 0.04 |
| EarningsYield | 0.01 | -0.08 | 0.07 | 0.05 | 0.39 |
After reviewing the key financial ratios for Ambica Agarbathies Aroma & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from -2.13 (Mar 24) to 4.66, marking an increase of 6.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from -2.13 (Mar 24) to 4.66, marking an increase of 6.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 3. It has increased from -1.15 (Mar 24) to 1.45, marking an increase of 2.60.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.62. It has increased from 58.96 (Mar 24) to 63.62, marking an increase of 4.66.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.62. It has increased from 58.96 (Mar 24) to 63.62, marking an increase of 4.66.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.96. It has increased from 56.96 (Mar 24) to 71.96, marking an increase of 15.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 9.05. This value is within the healthy range. It has increased from 5.75 (Mar 24) to 9.05, marking an increase of 3.30.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.89. This value is within the healthy range. It has increased from 4.77 (Mar 24) to 7.89, marking an increase of 3.12.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from -1.31 (Mar 24) to 1.57, marking an increase of 2.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 2. It has increased from -2.13 (Mar 24) to 0.28, marking an increase of 2.41.
- For PBDIT Margin (%), as of Mar 25, the value is 12.58. This value is within the healthy range. It has increased from 10.10 (Mar 24) to 12.58, marking an increase of 2.48.
- For PBIT Margin (%), as of Mar 25, the value is 10.96. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 10.96, marking an increase of 2.59.
- For PBT Margin (%), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 10. It has increased from -2.30 (Mar 24) to 2.17, marking an increase of 4.47.
- For Net Profit Margin (%), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has increased from -3.74 (Mar 24) to 0.39, marking an increase of 4.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 15. It has increased from -3.61 (Mar 24) to 0.44, marking an increase of 4.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.99. This value is below the healthy minimum of 10. It has increased from 4.29 (Mar 24) to 6.99, marking an increase of 2.70.
- For Return On Assets (%), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -1.73 (Mar 24) to 0.21, marking an increase of 1.94.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.66 (Mar 24) to 0.54, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has increased from 0.66 (Mar 24) to 0.68, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has increased from 0.47 (Mar 24) to 0.56, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.66 (Mar 24) to 2.69, marking a decrease of 0.97.
- For Quick Ratio (X), as of Mar 25, the value is 2.52. This value exceeds the healthy maximum of 2. It has decreased from 3.39 (Mar 24) to 2.52, marking a decrease of 0.87.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.76. This value is within the healthy range. It has increased from 4.36 (Mar 24) to 4.76, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 3. It has increased from 0.94 (Mar 24) to 1.43, marking an increase of 0.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 3. It has increased from 0.64 (Mar 24) to 1.04, marking an increase of 0.40.
- For Enterprise Value (Cr.), as of Mar 25, the value is 120.12. It has increased from 111.28 (Mar 24) to 120.12, marking an increase of 8.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 1.14 (Mar 24) to 0.97, marking a decrease of 0.17.
- For EV / EBITDA (X), as of Mar 25, the value is 7.72. This value is within the healthy range. It has decreased from 11.26 (Mar 24) to 7.72, marking a decrease of 3.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
- For Price / BV (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 1. It has decreased from 0.44 (Mar 24) to 0.42, marking a decrease of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 24) to 0.01, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambica Agarbathies Aroma & Industries Ltd:
- Net Profit Margin: 0.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.99% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.44% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.04
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.52
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 85.7 (Industry average Stock P/E: 57.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.68
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.39%
About the Company
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Shankar Towers, Power Pet, West Godavari Dist. Andhra Pradesh 534002 | ambica.a@rediffmail.com http://ambicaagarbathi.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ambica Krishna | Chairman & Managing Director |
| Mrs. Satyavathi Perla | Whole Time Director |
| Mr. Ambica Ramachandra Rao | Whole Time Director |
| Mr. Sreedharan Venkatesan | Independent Director |
| Mr. Chunduru Anjaneya Swamy | Independent Director |
| Mr. B V Subrahmanyeswarao | Independent Director |
Ambica Agarbathies & Aroma Industries Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹28.29 |
| Previous Day | ₹28.43 |
FAQ
What is the intrinsic value of Ambica Agarbathies Aroma & Industries Ltd?
Ambica Agarbathies Aroma & Industries Ltd's intrinsic value (as of 05 December 2025) is 20.52 which is 19.21% lower the current market price of 25.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 43.7 Cr. market cap, FY2025-2026 high/low of 37.0/23.3, reserves of ₹95 Cr, and liabilities of 224 Cr.
What is the Market Cap of Ambica Agarbathies Aroma & Industries Ltd?
The Market Cap of Ambica Agarbathies Aroma & Industries Ltd is 43.7 Cr..
What is the current Stock Price of Ambica Agarbathies Aroma & Industries Ltd as on 05 December 2025?
The current stock price of Ambica Agarbathies Aroma & Industries Ltd as on 05 December 2025 is 25.4.
What is the High / Low of Ambica Agarbathies Aroma & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambica Agarbathies Aroma & Industries Ltd stocks is 37.0/23.3.
What is the Stock P/E of Ambica Agarbathies Aroma & Industries Ltd?
The Stock P/E of Ambica Agarbathies Aroma & Industries Ltd is 85.7.
What is the Book Value of Ambica Agarbathies Aroma & Industries Ltd?
The Book Value of Ambica Agarbathies Aroma & Industries Ltd is 65.2.
What is the Dividend Yield of Ambica Agarbathies Aroma & Industries Ltd?
The Dividend Yield of Ambica Agarbathies Aroma & Industries Ltd is 0.00 %.
What is the ROCE of Ambica Agarbathies Aroma & Industries Ltd?
The ROCE of Ambica Agarbathies Aroma & Industries Ltd is 7.49 %.
What is the ROE of Ambica Agarbathies Aroma & Industries Ltd?
The ROE of Ambica Agarbathies Aroma & Industries Ltd is 0.45 %.
What is the Face Value of Ambica Agarbathies Aroma & Industries Ltd?
The Face Value of Ambica Agarbathies Aroma & Industries Ltd is 10.0.